Innovation Pharmaceuticals – Clinical Trial Testing of Brilacidin Against SARS-CoV-2 (COVID-19) Targeted to Commence Q4 2020
13 juil. 2020 08h00 HE
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., July 13, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today provides perspectives on the planned...
Tonix Pharmaceuticals Enters into Research and Exclusive License Option Agreement with Kansas State University to Develop Vaccine Against COVID-19
13 juil. 2020 07h00 HE
|
Tonix Pharmaceuticals Holding Corp.
Research to Develop Live Replicating Vaccine (TNX-2300) to Protect Against COVID-19 Based on Bovine Parainfluenza Virus TNX-2300 Will Be Tonix’s Second Live Replicating Virus Vaccine Platform ...
Pfizer und BioNTech erhalten FDA-Fast-Track-Status für zwei mRNA-basierte Impfstoffkandidaten gegen SARS-CoV-2
13 juil. 2020 06h45 HE
|
BioNTech SE
NEW YORK und MAINZ, Deutschland, July 13, 2020 (GLOBE NEWSWIRE) -- Pfizer Inc. (NYSE: PFE) und BioNTech SE (Nasdaq: BNTX, „BioNTech”) gaben heute bekannt, dass zwei der vier in Entwicklung...
Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2
13 juil. 2020 06h45 HE
|
BioNTech SE
NEW YORK and MAINZ, Germany, July 13, 2020 (GLOBE NEWSWIRE) -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that two of the companies’ four investigational...
Update on HIV-BLA-PDUFA: FDA requested more information to complete a substantive review. No additional trials required. CytoDyn plans to submit the requested information and will ask for a Type A meeting with the FDA per the agency’s suggestion
13 juil. 2020 06h00 HE
|
CytoDyn Inc.
Update on COVID-19: CytoDyn is planning to lock and unblind the Phase 2 COVID-19 trial data later this week. Periodic safety review by Data Safety Monitoring Committee (DSMC) for ongoing Phase 3 study...
Clinical Trial Shows Itolizumab Reduces Mortality in Patients Hospitalized with COVID-19
13 juil. 2020 03h30 HE
|
Equillium
Equillium shares topline results of patients treated with itolizumab in clinical trial conducted in India by partner Biocon Biocon has received emergency use approval from Drugs Controller General of...
Junshi Biosciences Announces Completion of Enrollment in Phase I Trial of SARS-CoV-2 Neutralizing Antibody JS016 in China
12 juil. 2020 20h00 HE
|
Junshi Biosciences
SHANGHAI, China, July 12, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and...
Microshare Closes $5mn+ in Financing to Fuel Growth in Facilities Safety and Intelligence Solutions
09 juil. 2020 12h00 HE
|
Microshare.io
PHILADELPHIA, July 09, 2020 (GLOBE NEWSWIRE) -- Defying the worst environment for raising capital in modern times, Microshare Inc. announced Thursday the successful closing of $5mn in funding with...
Breaking: U.S. Navy Reverses Course, Ends Ban on Troops Attending Indoor Religious Services
09 juil. 2020 10h02 HE
|
First Liberty Institute
First Liberty Institute urged U.S. Navy to accommodate the religious beliefs of its service members and chaplains to attend in-person religious services WASHINGTON, July 09, 2020 (GLOBE NEWSWIRE)...
Q BioMed, Inc. CEO Discusses Recently Announced Global Distribution Partnership with Caligor Coghlan Pharma Services in Audio Interview with SmallCapVoice.com
09 juil. 2020 08h00 HE
|
Q BioMed Inc.
AUSTIN, Texas, July 09, 2020 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with Q BioMed Inc. (“the Company”) (OTCQB: QBIO), a commercial...